ReviewPolymers2023
Biocompatible and Biodegradable 3D Printing from Bioplastics: A Review.
Review in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 76 citations in OpenAlex.
- Article
- Investigating Rheological Behavior ofPolymers · 2026Article
- The Future of Sustainable Packaging: Exploring Biodegradable Solutions Through Extrusion, Thermo-Expansion, 3D Printing and Supercritical Fluid from Agro-Industry Waste.Foods (Basel, Switzerland) · 2025Review
- Advanced Biocompatible and Biodegradable Polymers: A Review of Functionalization, Smart Systems, and Sustainable Applications.Polymers · 2025Review
- Redesigning FDM Platforms for Bio-Printing Applications.Micromachines · 2025Review
- Development of a systematic coarse-grained model for poly(ε-caprolactone) in melt.Open research Europe · 2025Article
- A modular and flexible open source cell incubator system for mobile and stationary use.HardwareX · 2024Article
- Review
- Cellulose/Polyhydroxybutyrate (PHB) Composites as a Sustainable Bio-Based Feedstock to 3D-Printing Applications.Materials (Basel, Switzerland) · 2024Article
- Development of Biocompatible 3D-Printed Artificial Blood Vessels through Multidimensional Approaches.Journal of functional biomaterials · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
Abstract
There has been a lot of interest in developing and producing biodegradable polymers to address the current environmental problem caused by the continued usage of synthetic polymers derived from petroleum products. Bioplastics have been identified as a possible alternative to the use of conventional plastics since they are biodegradable and/or derived from renewable resources. Additive manufacturing, also referred to as 3D printing, is a field of growing interest and can contribute towards a sustainable and circular economy. The manufacturing technology also provides a wide material selection with design flexibility increasing its usage in the manufacture of parts from bioplastics. With this material flexibility, efforts have been directed towards developing 3D printing filaments from bioplastics such as Poly (lactic acid) to substitute the common fossil- based conventional plastic filaments such as Acrylonitrile butadiene styrene. Plant biomass is now utilized in the development of biocomposite materials. A lot of literature presents work done toward improving the biodegradability of printing filaments. However, additive manufacture of biocomposites from plant biomass is faced with printing challenges such as warping, low agglomeration between layers and poor mechanical properties of the printed parts. The aim of this paper is to review the technology of 3D printing using bioplastics, study the materials that have been utilized in this technology and how challenges of working with biocomposites in additive manufacture have been addressed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.